Marsh & McLennan (MRSH) awards director 192 shares

Rhea-AI Filing Summary

MARSH & MCLENNAN COMPANIES, INC. (MRSH) reported that director Bruce D. Broussard received a grant of 192 shares of Common Stock on 2026-08-15. The award, valued at $188.445 per share, was acquired as part of director fees under the Marsh & McLennan Companies Directors Stock Compensation Plan. Following this grant, Broussard directly holds 1,617 shares of MRSH common stock.

Insider Trade Summary

Net Buyer: 192 shares

Net Buy 1 txn

Insider BROUSSARD BRUCE D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	192	$188.445	$36K

Holdings After Transaction: Common Stock — 1,617 shares (Direct)

Footnotes (1)

1. F1. Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan.

Key Figures

Shares granted: 192 shares Grant value per share: $188.445 per share Shares owned after transaction: 1,617 shares

3 metrics

Shares granted 192 shares Common Stock grant to director Bruce D. Broussard on 2026-08-15

Grant value per share $188.445 per share Reported value for the 192-share Common Stock director fee award

Shares owned after transaction 1,617 shares Bruce D. Broussard’s direct MRSH Common Stock holdings following the grant

Key Terms

Directors Stock Compensation Plan, grant/award acquisition, non-derivative

3 terms

Directors Stock Compensation Plan financial

"Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan"

grant/award acquisition financial

"transaction_action is labeled as grant/award acquisition for the reported shares"

non-derivative financial

"The reported Common Stock transaction is classified as non-derivative"

FAQ

What insider transaction did MRSH disclose for Bruce D. Broussard?

Bruce D. Broussard received a grant of 192 MRSH common shares on 2026-08-15 as part of his director fees. The shares were awarded under the Marsh & McLennan Companies Directors Stock Compensation Plan, increasing his direct holdings to 1,617 shares.

At what price was the MRSH director stock grant to Bruce D. Broussard valued?

The 192-share stock grant to Bruce D. Broussard was valued at $188.445 per share. This per-share value is reported for the non-derivative Common Stock award made in connection with his director compensation plan.

How many MRSH shares does Bruce D. Broussard own after the reported Form 4 transaction?

After the 192-share grant, Bruce D. Broussard directly holds 1,617 shares of MRSH common stock. This total reflects his updated direct ownership position immediately following the August 15, 2026 director fee-related award.

Was the MRSH Form 4 transaction by Bruce D. Broussard a purchase or a grant?

The MRSH Form 4 shows a grant/award acquisition of 192 shares, not an open-market purchase. The Common Stock was acquired as director fees under the company’s Directors Stock Compensation Plan rather than through a market transaction.

Does the reported MRSH Form 4 involve derivative securities for Bruce D. Broussard?

No, the filing reports a non-derivative transaction in MRSH Common Stock only. There are no derivative security exercises, conversions, or remaining derivative positions listed for Bruce D. Broussard in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/18/2026 - 04:01 PM Accepted by SEC EDGAR 08/18/2026 - 04:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BROUSSARD BRUCE D

(Last) (First) (Middle)

1166 AVENUE OF THE AMERICAS

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARSH & MCLENNAN COMPANIES, INC. [ MRSH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2026		A(1)		192	A	$188.445	1,617	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan.

	/s/ Tessa Patti, Attorney-in-fact	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)